Credit: Getty Images. Prior authorization requirements for oral cancer drugs on Medicare part D formularies have increased in recent years, research suggests. Prior authorization requirements for oral ...
(Reuters) -Biogen Inc said on Tuesday the European Commission has revoked the marketing authorization for generic versions of its multiple sclerosis drug Tecfidera held by the firms Accord, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback